{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:52:05Z","timestamp":1782816725831,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.fertnstert.2012.11.034","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T14:31:02Z","timestamp":1356013862000},"page":"1305-1310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Antim\u00fcllerian hormone levels decrease in women using combined contraception independently of administration route"],"prefix":"10.1016","volume":"99","clinical-trial-number":[{"clinical-trial-number":"2007-004984-23","registry":"10.18810\/euctr"},{"clinical-trial-number":"nct01087879","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Sanna","family":"Kallio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Puurunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimo","family":"Ruokonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi","family":"Vaskivuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Piltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha S.","family":"Tapanainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2012.11.034_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/13625180410001715681","article-title":"Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries","volume":"9","author":"Skouby","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9378(77)90295-2","article-title":"The effect of contraceptive steroids on hypothalamic-pituitary function","volume":"128","author":"Mishell","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0010-7824(90)90001-C","article-title":"Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users","volume":"42","author":"van der Spuy","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2007.11.005","article-title":"Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens","volume":"77","author":"Vandever","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0010-7824(99)00025-6","article-title":"Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives","volume":"59","author":"van Heusden","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2006.02.006","article-title":"Greater inhibition of the pituitary\u2013ovarian axis in oral contraceptive regimens with a shortened hormone-free interval","volume":"74","author":"Willis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","article-title":"Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity","volume":"72","author":"Sullivan","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.contraception.2011.02.013","article-title":"Current issues and available options in combined hormonal contraception","volume":"84","author":"Bitzer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib13","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antim\u00fcllerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antim\u00fcllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib16","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-M\u00fcllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib17","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-M\u00fcllerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fertnstert.2007.04.054","article-title":"Statistically significant changes of antim\u00fcllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women","volume":"89","author":"Wunder","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","article-title":"Serum antim\u00fcllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids","volume":"90","author":"Streuli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib20","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/humrep\/dem258","article-title":"Serum anti-m\u00fcllerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills","volume":"22","author":"Arbo","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-M\u00fcllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib22","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/humrep\/deq071","article-title":"Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases","volume":"25","author":"van den Berg","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib23","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.fertnstert.2011.05.051","article-title":"Serum antim\u00fcllerian hormone in healthy premenopausal women","volume":"95","author":"Shaw","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/uog.10114","article-title":"Quantifying the effect of the combined oral contraceptive pill on the functional ovarian reserve as measured by serum anti-M\u00fcllerian hormone and the small antral follicle count made using three-dimensional ultrasound","volume":"39","author":"Deb","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.fertnstert.2011.12.017","article-title":"The association between circulating levels of antim\u00fcllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women","volume":"97","author":"Kristensen","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/09513590.2010.487595","article-title":"The effect of different hormone therapies on anti-m\u00fcllerian hormone serum levels in anovulatory women of reproductive age","volume":"27","author":"Fabregues","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.contraception.2010.09.007","article-title":"Serum anti-m\u00fcllerian hormone level is not altered in women using hormonal contraceptives","volume":"83","author":"Li","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib28","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/humrep\/des225","article-title":"Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study","volume":"27","author":"Piltonen","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.humrep.a136365","article-title":"Dynamics of follicular growth in the human: a model from preliminary results","volume":"1","author":"Gougeon","year":"1986","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","article-title":"Regulation of ovarian follicular development in primates: facts and hypotheses","volume":"17","author":"Gougeon","year":"1996","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib31","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/jrf.0.1130027","article-title":"Effect of androgens on the development of mouse follicles growing in\u00a0vitro","volume":"113","author":"Murray","year":"1998","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib33","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-m\u00fcllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum m\u00fcllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women","volume":"77","author":"Cook","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib35","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1210\/endo.136.11.7588229","article-title":"Anti-m\u00fcllerian hormone and anti-m\u00fcllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth","volume":"136","author":"Baarends","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib36","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1095\/biolreprod.104.028175","article-title":"Estrogen actions on follicle formation and early follicle development","volume":"71","author":"Britt","year":"2004","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib37","first-page":"192","article-title":"Roles of estrogen receptor alpha (ER alpha) in the regulation of the human M\u00fcllerian inhibitory substance (MIS) promoter","volume":"50","author":"Chen","year":"2003","journal-title":"J Med Invest"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib38","doi-asserted-by":"crossref","first-page":"E1649","DOI":"10.1210\/jc.2011-3133","article-title":"Differential regulation of ovarian anti-M\u00fcllerian hormone (AMH) by estradiol through alpha- and beta-estrogen receptors","volume":"97","author":"Grynberg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib39","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.fertnstert.2010.01.018","article-title":"Does estrogen directly modulate anti-m\u00fcllerian hormone secretion in women?","volume":"94","author":"Liberty","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib40","first-page":"3722","article-title":"Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene","volume":"81","author":"Aittom\u00e4ki","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/17.1.88","article-title":"The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries","volume":"17","author":"Barnes","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng0297-201","article-title":"Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility","volume":"15","author":"Kumar","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1095\/biolreprod48.3.585","article-title":"Hypophysectomy of the cyclic mouse. I. Effects on folliculogenesis, oocyte growth, and follicle-stimulating hormone and human chorionic gonadotropin receptors","volume":"48","author":"Wang","year":"1993","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/jrf.0.0780119","article-title":"Effects of gonadotrophin deficiency on follicular development in hypogonadal (hpg) mice","volume":"78","author":"Halpin","year":"1986","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib45","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jc.2011-0368","article-title":"The role of anti-m\u00fcllerian hormone (AMH) in assessing ovarian reserve","volume":"96","author":"Tran","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib46","first-page":"200","article-title":"Initial and cyclic recruitment of ovarian follicles","volume":"21","author":"McGee","year":"2000","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/09513590.2010.507283","article-title":"The impact of oral contraceptives and metformin on anti-M\u00fcllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia","volume":"27","author":"Panidis","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2009.10.004","article-title":"Antim\u00fcllerian hormone and obesity: insights in oral contraceptive users","volume":"81","author":"Steiner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib49","first-page":"1401","article-title":"Measurement of dimeric inhibin B throughout the human menstrual cycle","volume":"81","author":"Groome","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib50","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.fertnstert.2006.04.032","article-title":"Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness","volume":"86","author":"Luisi","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0010-7824(97)00206-0","article-title":"Dimeric inhibin serum values as markers of ovarian activity in pill-free intervals","volume":"57","author":"Renier","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2012.11.034_bib52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2007.09.010","article-title":"Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive","volume":"77","author":"Reape","year":"2008","journal-title":"Contraception"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028212024466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028212024466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:02:09Z","timestamp":1758009729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028212024466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0015028212024466"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.11.034","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969763.793481035","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717969763.793469272","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717969763.793477571","asserted-by":"object"}]},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antim\u00fcllerian hormone levels decrease in women using combined contraception independently of administration route","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}